Intensive chemotherapy with idarubicin, ara-C, etoposide, and m-AMSA followed by immunotherapy with interleukin-2 for myelodysplastic syndromes and high-risk Acute Myeloid Leukemia (AML)
Titel:
Intensive chemotherapy with idarubicin, ara-C, etoposide, and m-AMSA followed by immunotherapy with interleukin-2 for myelodysplastic syndromes and high-risk Acute Myeloid Leukemia (AML)
Auteur:
Ganser, A. Heil, G. Seipelt, G. Hofmann, W. Fischer, J. T. Langer, W. Brockhaus, W. Kolbe, K. Ittel, T. H. Brack, N. Fuhr, H. G. Knuth, P. Höffken, K. Bergmann, L. Hoelzer, D.